Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Walsh graduated cum laude from Georgetown University with a B.S. in Biology and went on to complete his medical and doctoral training in the NIH-funded MSTP MD/PhD program at The University of Cincinnati College of Medicine. Dr. Walsh then received both post-doctoral training in functional magnetic resonance imaging (fMRI) and residency training in Neurology at The University of Chicago Medical Center. Dr. Walsh subsequently pursued fellowship training in Movement Disorders with Dr. David Standaert and Dr. Ray Watts at The University of Alabama at Birmingham. During fellowship, Dr. Walsh developed an MRI-based analysis of structural and functional brain networks underlying cognitive dysfunction in Parkinson’s disease and received competitive funding from the Parkinson’s Disease Foundation and Civitan Research Foundation in support of this work.
Dr. Walsh joined Cleveland Clinic Lou Ruvo Center for Brain Health in July 2011 as inaugural Director of the Parkinson’s Disease and Movement Disorders Program, and has stewarded the development of several programs new to the center including the Huntington’s Disease Comprehensive Clinic, the development of the Lou Ruvo Center for Brain Health as a research site for both the Parkinson Study Group (where he is a member of both the Biomarkers and Cognitive Working Groups) and Huntington Study Group, and the development of clinical trial and investigator initiated research in Parkinson’s Disease. Dr. Walsh has published and presented in the field of Parkinson’s Disease with emphasis on cognitive impairment, and his efforts have recently been recognized by the American Academy of Neurology (AAN) where he was one of 13 individuals selected for the inaugural AAN Emerging Leaders Program and where he was recently selected to serve on the AAN Science Committee as well.
Parkinson's disease, movement disorders, atypical parkinsonism, corticobasal degeneration, progressive supranuclear palsy, multiple systems atrophy, huntington's disease, essential tremors, ataxia
Specialty and Research Interests:
- Cognitive Impairment in Parkinson's Disease and Atypical parkinsonism
- Gait freezing in Parkinson's Disease and Atypical parkinsonism
- MRI and fMRI-based analyses of brain networks involved in cognitive impairment and abnormal movements in Parkinson's Disease and other Movement Disorders
- Deep Brain Stimulation (DBS) therapy for Parkinson's Disease and other Movement Disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/8/2014, Dr. Walsh has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.